Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.
The report details the trend, potential and market size of Therapeutic Nuclear Medicines market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Therapeutic Nuclear Medicinesmarket, defines the market attractiveness level of Therapeutic Nuclear Medicines market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Therapeutic Nuclear Medicines industry, describes the types of Therapeutic Nuclear Medicines market, the applications of major players and the market size, and deeply analyzes the current situation of the global Therapeutic Nuclear Medicines market and the development prospects and opportunities of Therapeutic Nuclear Medicines industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Therapeutic Nuclear Medicines market in Chapter 13.
By Player:
International Isotopes
Jubilant DraxImage
Curium Pharmaceuticals
China Isotope & Radiation
Progenics Pharmaceuticals
Bayer
Q BioMed
Lantheus
Novartis AG
Dongcheng
Spectrum Pharmaceuticals
By Type:
Radium-223
Lutetium-177
Iodine-131
Other
By End-User:
Thyroid
Bone Metastasis
Lymphoma
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Therapeutic Nuclear Medicines Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Therapeutic Nuclear Medicines Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Therapeutic Nuclear Medicines Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Therapeutic Nuclear Medicines Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Therapeutic Nuclear Medicines Market Analysis and Outlook to 2022
-
7.1 Global Therapeutic Nuclear Medicines Consumption (2017-2022)
-
7.2 United States Therapeutic Nuclear Medicines Consumption (2017-2022)
-
7.3 Europe Therapeutic Nuclear Medicines Consumption (2017-2022)
-
7.4 China Therapeutic Nuclear Medicines Consumption (2017-2022)
-
7.5 Japan Therapeutic Nuclear Medicines Consumption (2017-2022)
-
7.6 India Therapeutic Nuclear Medicines Consumption (2017-2022)
-
7.7 South Korea Therapeutic Nuclear Medicines Consumption (2017-2022)
8 Region and Country-wise Therapeutic Nuclear Medicines Market Analysis and Outlook to 2028
-
8.1 Global Therapeutic Nuclear Medicines Consumption Forecast (2022-2028)
-
8.2 United States Therapeutic Nuclear Medicines Consumption Forecast (2022-2028)
-
8.3 Europe Therapeutic Nuclear Medicines Consumption Forecast (2022-2028)
-
8.4 China Therapeutic Nuclear Medicines Consumption Forecast (2022-2028)
-
8.5 Japan Therapeutic Nuclear Medicines Consumption Forecast (2022-2028)
-
8.6 India Therapeutic Nuclear Medicines Consumption Forecast (2022-2028)
-
8.7 South Korea Therapeutic Nuclear Medicines Consumption Forecast (2022-2028)
9 Global Therapeutic Nuclear Medicines Market Outlook by Types and Applications to 2022
-
9.1 Global Therapeutic Nuclear Medicines Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Radium-223 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Lutetium-177 Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Iodine-131 Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global Therapeutic Nuclear Medicines Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Thyroid Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Bone Metastasis Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Lymphoma Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Other Consumption and Growth Rate (2017-2022)
10 Global Therapeutic Nuclear Medicines Market Outlook by Types and Applications to 2028
-
10.1 Global Therapeutic Nuclear Medicines Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Radium-223 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Lutetium-177 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Iodine-131 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Therapeutic Nuclear Medicines Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Thyroid Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Bone Metastasis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Lymphoma Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Therapeutic Nuclear Medicines Import and Export Analysis (Top 5 Countries)
-
11.1 Global Therapeutic Nuclear Medicines Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Therapeutic Nuclear Medicines Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Therapeutic Nuclear Medicines Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Therapeutic Nuclear Medicines Market Competitive Analysis
-
14.1 International Isotopes
-
14.1.1 International Isotopes Company Details
-
14.1.2 International Isotopes Therapeutic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 International Isotopes Therapeutic Nuclear Medicines Product and Service
-
14.2 Jubilant DraxImage
-
14.2.1 Jubilant DraxImage Company Details
-
14.2.2 Jubilant DraxImage Therapeutic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Jubilant DraxImage Therapeutic Nuclear Medicines Product and Service
-
14.3 Curium Pharmaceuticals
-
14.3.1 Curium Pharmaceuticals Company Details
-
14.3.2 Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Curium Pharmaceuticals Therapeutic Nuclear Medicines Product and Service
-
14.4 China Isotope & Radiation
-
14.4.1 China Isotope & Radiation Company Details
-
14.4.2 China Isotope & Radiation Therapeutic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 China Isotope & Radiation Therapeutic Nuclear Medicines Product and Service
-
14.5 Progenics Pharmaceuticals
-
14.5.1 Progenics Pharmaceuticals Company Details
-
14.5.2 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Product and Service
-
14.6 Bayer
-
14.6.1 Bayer Company Details
-
14.6.2 Bayer Therapeutic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Bayer Therapeutic Nuclear Medicines Product and Service
-
14.7 Q BioMed
-
14.7.1 Q BioMed Company Details
-
14.7.2 Q BioMed Therapeutic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Q BioMed Therapeutic Nuclear Medicines Product and Service
-
14.8 Lantheus
-
14.8.1 Lantheus Company Details
-
14.8.2 Lantheus Therapeutic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Lantheus Therapeutic Nuclear Medicines Product and Service
-
14.9 Novartis AG
-
14.9.1 Novartis AG Company Details
-
14.9.2 Novartis AG Therapeutic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Novartis AG Therapeutic Nuclear Medicines Product and Service
-
14.10 Dongcheng
-
14.10.1 Dongcheng Company Details
-
14.10.2 Dongcheng Therapeutic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Dongcheng Therapeutic Nuclear Medicines Product and Service
-
14.11 Spectrum Pharmaceuticals
-
14.11.1 Spectrum Pharmaceuticals Company Details
-
14.11.2 Spectrum Pharmaceuticals Therapeutic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Spectrum Pharmaceuticals Therapeutic Nuclear Medicines Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Therapeutic Nuclear Medicines
-
Figure Therapeutic Nuclear Medicines Picture
-
Table Global Therapeutic Nuclear Medicines Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Therapeutic Nuclear Medicines Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Therapeutic Nuclear Medicines Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Therapeutic Nuclear Medicines Consumption by Country (2017-2022)
-
Figure United States Therapeutic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Table Europe Therapeutic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure China Therapeutic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure Japan Therapeutic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure India Therapeutic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure South Korea Therapeutic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure Global Therapeutic Nuclear Medicines Consumption Forecast by Country (2022-2028)
-
Figure United States Therapeutic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Therapeutic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Therapeutic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Therapeutic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Therapeutic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Therapeutic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Radium-223 Consumption and Growth Rate (2017-2022)
-
Figure Global Lutetium-177 Consumption and Growth Rate (2017-2022)
-
Figure Global Iodine-131 Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Thyroid Consumption and Growth Rate (2017-2022)
-
Figure Global Bone Metastasis Consumption and Growth Rate (2017-2022)
-
Figure Global Lymphoma Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Radium-223 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lutetium-177 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Iodine-131 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Thyroid Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Bone Metastasis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lymphoma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Therapeutic Nuclear Medicines Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Therapeutic Nuclear Medicines Export by Region (Top 5 Countries) (2017-2028)
-
Table International Isotopes (Foundation Year, Company Profile and etc.)
-
Table International Isotopes Therapeutic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
Table International Isotopes Therapeutic Nuclear Medicines Product and Service
-
Table Jubilant DraxImage (Foundation Year, Company Profile and etc.)
-
Table Jubilant DraxImage Therapeutic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Jubilant DraxImage Therapeutic Nuclear Medicines Product and Service
-
Table Curium Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Curium Pharmaceuticals Therapeutic Nuclear Medicines Product and Service
-
Table China Isotope & Radiation (Foundation Year, Company Profile and etc.)
-
Table China Isotope & Radiation Therapeutic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
Table China Isotope & Radiation Therapeutic Nuclear Medicines Product and Service
-
Table Progenics Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Progenics Pharmaceuticals Therapeutic Nuclear Medicines Product and Service
-
Table Bayer (Foundation Year, Company Profile and etc.)
-
Table Bayer Therapeutic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Therapeutic Nuclear Medicines Product and Service
-
Table Q BioMed (Foundation Year, Company Profile and etc.)
-
Table Q BioMed Therapeutic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Q BioMed Therapeutic Nuclear Medicines Product and Service
-
Table Lantheus (Foundation Year, Company Profile and etc.)
-
Table Lantheus Therapeutic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lantheus Therapeutic Nuclear Medicines Product and Service
-
Table Novartis AG (Foundation Year, Company Profile and etc.)
-
Table Novartis AG Therapeutic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG Therapeutic Nuclear Medicines Product and Service
-
Table Dongcheng (Foundation Year, Company Profile and etc.)
-
Table Dongcheng Therapeutic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Dongcheng Therapeutic Nuclear Medicines Product and Service
-
Table Spectrum Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Spectrum Pharmaceuticals Therapeutic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Spectrum Pharmaceuticals Therapeutic Nuclear Medicines Product and Service
-
